Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01722916 · ClinicalTrials.gov registry record · Early Phase 1
Reducing and Removing Hyaluronic Acid Filler With Hyaluronidase
A Early Phase 1 study of Drug Safety, sponsored by Northwestern University.
- Active
- Registry status
- Early Phase 1
- Development phase
- 5
- Enrollment target
- 1
- Study location
NCT01722916 is a Early Phase 1 study of Drug Safety that is active but no longer recruiting, run by Northwestern University. The registered enrollment target is 5 participants, below the 103-participant average among 4 other Drug Safety trials with a reported enrollment target (95% lower). The trial reports 1 study location across 1 state.
The verdict
NCT01722916, a Early Phase 1 study of Drug Safety, is active but no longer recruiting, sponsored by Northwestern University.
- ACTIVE NOT RECRUITING
- Registry status
- Early Phase 1
- Development phase
- 5 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to find how much hyaluronidase should be used when receiving injections of fillers.
Conditions Studied
Interventions
- DRUG Hyaluronidase
Study Locations (1)
Illinois
- Northwestern University Department of Dermatology - Chicago
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 5 participants |
| Start Date | 2012-10 |
| Est. Completion | 2025-12 |
| Phase | Early Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01722916
The ClinicalTrials.gov registry entry for NCT01722916 describes a study currently listed as active not recruiting, categorized as Early Phase 1. The registered enrollment target is 5 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 103-participant average among 4 other Drug Safety trials with a reported enrollment target (95% lower). The listed sponsor is Northwestern University, which has 1,209 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Drug Safety appearing as the primary indexed condition, and to 1 intervention - of which Hyaluronidase is the first listed.
NCT01722916 reports 1 study location spanning 1 distinct geographic area - top geographies include Illinois.
Frequently Asked Questions
What is clinical trial NCT01722916 about?
NCT01722916 is a clinical study titled "Reducing and Removing Hyaluronic Acid Filler With Hyaluronidase". The purpose of this study is to find how much hyaluronidase should be used when receiving injections of fillers.
What is the current status of trial NCT01722916?
This trial is currently active not recruiting. It is a Early Phase 1 study. The enrollment target is 5 participants. The study started on 2012-10. Estimated completion is 2025-12.
What conditions does trial NCT01722916 study?
This clinical trial studies the following conditions: Drug Safety.
What interventions are being tested in trial NCT01722916?
The interventions under investigation include: Hyaluronidase (DRUG).
Who is sponsoring clinical trial NCT01722916?
This trial is sponsored by Northwestern University, which has 1,209 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01722916 being conducted?
This trial has 1 study location across Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Drug Safety
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Comparing Patient Comfort and Safety Between Iodixanol and Iopamidol in Patients Undergoing Peripheral Arteriography
COMPLETED · Phase 4
-
Safety and Pharmacokinetics Study of CARD-024 in Healthy Subjects
COMPLETED · Phase 1
-
Clinical Safety of a Novel Milk Protein Peptide
COMPLETED · Phase 1
-
Ascending Multiple-Dose Study to Evaluate VIA-3196 in Healthy Subjects
COMPLETED · Phase 1
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.